Hydroxyprogesterone Caproate

Records for this ingredient, by country (identity only).

ATC — · 3 markets · 6 records

Hydroxyprogesterone Caproate 3 markets · 6 records Forms
Filters
MarketTW 3US 2CN 1

TW 3 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名"台裕"已醯羥化黃體素注射液 ×1CAPRONE INJECTION ×1HYDROXYPROGESTERONE CAPROATE INJECTIONS "TAI YU" ×1確普榮注射液 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

  • 1,250 mg/5 mLinjectionManufacturer: Eugia US LLC
  • 250 mg per mL / per unit basis not statedinjectionManufacturer: Fresenius Kabi Austria GmbH

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 1 mL per mL / per unit basis not statedinjectionManufacturer: 华中药业股份有限公司

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.